The level of miR-124 was downregulated in AD brain, which was involved in negatively regulating BACE1 expression and accumulation of Aβ [93], which indicates the miR-124 expression has the potential to generate novel diagnostic and therapeutic strategies to AD. Here, BACE1 is linked to Alzheimer disease.